Press Release Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update Aug 17
Press Release Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call Aug 6
Press Release Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer Jul 30